Clinical Trial Update: A Multicenter Two-Cohort Study of Methotrexate, Rituximab, Sintilimab and Pirtobrutinib for Treatment-Naive PCNSL vs. Real-World Investigator-Selected Treatment (Observational Cohort) [Phase 2]

View source ↗

Summary

This is a Phase 2 multicenter observational study enrolling treatment-naive primary central nervous system lymphoma patients to compare a regimen of methotrexat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Pirtobrutinib (pirtobrutinib)
• Rituxan (rituximab)
• Sintilimab (sintilimab)

Snippet

Sponsor: Tongji Hospital | Conditions: PCNSL, Primary Central Nervous System Lymphoma | Phase 2 | Status: RECRUITING